Stock Analiz

DiaMedica Therapeutics Inc. (DMAC) stock forecast and price target

Price $8.79 · data as of November 13, 2026

12-month price target

Average target$15.50
Upside / downside+76.3%
Analysts4
ConsensusStrong buy
Low $11.00Average $15.50High $25.00

Gold marker: average target · white marker: today’s price ($8.79)

Analyst ratings

Strong buy 0Buy 5Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.79−12.9%$0
Next fiscal year
ends December 31, 2027
$-0.75+5.1%$0
Next quarter
ends December 31, 2026
$-0.21−23.5%$0
Quarter after
ends March 31, 2027
$-0.19+0.0%$0

Consensus of the analysts covering DiaMedica Therapeutics, updated daily. In the last 30 days 3 estimates were raised and 0 lowered.

Frequently asked questions

What is the DiaMedica Therapeutics stock price target?

The average 12-month target from 4 analysts is $15.50, 76.3% above the current price of $8.79 Targets range from $11.00 to $25.00.

Is DiaMedica Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (5 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is DiaMedica Therapeutics expected to earn?

Analysts expect EPS of $-0.79 for the fiscal year ending December 31, 2026 and $-0.75 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.